An eight-week randomised, 3-arm, double-blind study to compare the safety and efficacy of the combination of telmisartan 40mg + amlodipine 10mg versus telmisartan 80mg + amlodipine 10mg versus amlodipine 10mg monotherapy in patients with hypertension who fail to respond adequately to treatment with amlodipine 10mg monotherapy.
- Registry ID
- EUCTR2007-002421-68
- Source registry
- EUCTR
- Status
- Completed
- Phase
- PHASE3
- Sponsor
- Boehringer Ingelheim Ltd
- Start date
- 2007-10-05
- Completion date
- 2008-10-17
- Last update
- 2026-08-16
Conditions
- essential hypertension
- Hipertensión esencial essential hypertension
Summary
To show that the combination of telmisartan (40 or 80mg) + amlodipine 10mg (A10) is superior to A10 monotherapy in reducing seated trough diastolic blood pressure (DBP) in patients who fail to respond to A10 monotherapy.
Locations
- , , Italy
- , , Czechia
- , , Spain
- , , Austria
- , , UK
- , , Bulgarian Drug Agency
- , , Ireland
- , , Slovakia
View on source registry